Multimodal Analgesic Protocol to Moderate Acute Pain
Prospective, Observational Study With a Multimodal Analgesic Protocol to Moderate Acute Pain After Third Molar Surgery
1 other identifier
observational
100
1 country
1
Brief Summary
With a prospective, observational study assess post-surgery pain levels and patient's use of opioids and other analgesic drugs to moderate pain following third molar surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2018
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 28, 2018
CompletedStudy Start
First participant enrolled
March 1, 2018
CompletedFirst Posted
Study publicly available on registry
March 7, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedFebruary 23, 2023
December 1, 2022
4.8 years
February 28, 2018
February 22, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
The impact of the surgery on the patient's post-surgery pain.
Likert scales for average pain and worst pain are assessed with 7-point scales with verbal anchors of "no pain" and "worst pain imagined". Recovery for pain on the Likert scales is defined as the number of PSD until the patient reports a score of 1 or 2 on the 7-point scale.
14 days
Interventions
The patient is asked to complete the diary each post-surgery day for 14 days. Recovery is organized into three QOL domains: lifestyle, oral function, and pain.
Eligibility Criteria
Patients scheduled for surgery at UNC oral and maxillofacial surgery clinic
You may qualify if:
- ASA I,II At least two lower 3rd molars scheduled for removal
You may not qualify if:
- Patient being treated for opioid addiction/abuse including having Rx for suboxone, methadone
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of North Carolina School of Dentistry
Chapel Hill, North Carolina, 27599-7450, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Glenn Reside, DMD
UNC oral and maxillofacial surgery
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 28, 2018
First Posted
March 7, 2018
Study Start
March 1, 2018
Primary Completion
December 31, 2022
Study Completion
December 31, 2022
Last Updated
February 23, 2023
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share